American Well (NYSE:AMWL) Insider Sells $29,547.50 in Stock

American Well Corporation (NYSE:AMWL) insider Dmitry Zamansky sold 5,575 shares of the business’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $5.30, for a total value of $29,547.50. Following the completion of the transaction, the insider directly owned 241,080 shares of the company’s stock, valued at approximately $1,277,724. The trade was a 2.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Dmitry Zamansky also recently made the following trade(s):

• On Friday, January 2nd, Dmitry Zamansky sold 6,243 shares of American Well stock. The stock was sold at an average price of $4.85, for a total value of $30,278.55.

American Well Price Performance

Shares of AMWL stock opened at $5.51 on Friday. The stock’s 50-day moving average is $5.23 and its 200 day moving average is $5.07. American Well Corporation has a 1-year low of $3.71 and a 1-year high of $9.15. The company has a market cap of $91.12 million, a P/E ratio of -0.93 and a beta of 1.39.

American Well (NYSE:AMWL) last announced its earnings results on Thursday, February 12th. The company reported ($1.52) EPS for the quarter, topping analysts’ consensus estimates of ($1.59) by $0.07. The business had revenue of $55.31 million during the quarter, compared to the consensus estimate of $52.71 million. American Well had a negative net margin of 38.38% and a negative return on equity of 35.33%. On average, analysts anticipate that American Well Corporation will post -9.34 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Headlands Technologies LLC purchased a new stake in shares of American Well in the second quarter valued at about $39,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in American Well during the third quarter worth about $62,000. Occudo Quantitative Strategies LP acquired a new position in American Well in the 4th quarter valued at about $74,000. NewEdge Advisors LLC acquired a new position in American Well in the 4th quarter valued at about $82,000. Finally, Prelude Capital Management LLC purchased a new stake in shares of American Well in the 3rd quarter valued at approximately $86,000. Institutional investors and hedge funds own 56.05% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Stifel Nicolaus cut their price objective on shares of American Well from $6.00 to $5.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Wall Street Zen upgraded shares of American Well from a “sell” rating to a “hold” rating in a research note on Sunday, March 22nd. Morgan Stanley dropped their target price on shares of American Well from $10.50 to $6.00 and set an “equal weight” rating on the stock in a research report on Thursday, December 18th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Well in a report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $7.42.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.